National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

Public Engagement
on Facilitating
Access to Antiviral
Medications and
Information in an
Influenza Pandemic

Workshop Series Summary

Barbara Fain, Kristin Viswanathan,
and Bruce M. Altevogt, Rapporteurs

Forum on Medical and Public Health Preparedness for
Catastrophic Events

Board on Health Sciences Policy

INSTITUTE OF MEDICINE
         OF THE NATIONAL ACADEMIES

THE NATIONAL ACADEMIES PRESS
Washington, D.C.
www.nap.edu

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

THE NATIONAL ACADEMIES PRESS • 500 Fifth Street, NW • Washington, DC 20001

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

This study was supported by contracts between the National Academy of Sciences and the American College of Emergency Physicians; the American Hospital Association; the American Medical Association; the American Nurses Association; the Association of State and Territorial Health Officials; the Centers for Disease Control and Prevention (Contract No. 200-2005-13434 TO #6); the Department of the Army (Contract No. W81XWH-08-P-0934); the Department of Health and Human Services’ National Institutes of Health (Contract No. N01-OD-4-2139 TO #198 and TO #244); the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (Contract Nos. HHSP233200900680P, HHS P23320042509X1); the Department of Homeland Security’s Federal Emergency Management Agency (Contract No. HSFEHQ-08-P-1800); the Department of Homeland Security’s Office of Health Affairs (Contract No. HSHQDC-07-C-00097); the Department of Transportation’s National Highway Traffic Safety Administration (Contract No. DTNH22-10-H-00287); the Department of Veterans Affairs (Contract No. V101(93)P-2136 TO #10); the Emergency Nurses Association; the National Association of Chain Drug Stores; the National Association of County and City Health Officials; the National Association of Emergency Medical Technicians; the Pharmaceutical Research and Manufacturers of America; the Robert Wood Johnson Foundation; and the United Health Foundation. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for the project.

International Standard Book Number-13: 978-0-309-25694-0

International Standard Book Number-10: 0-309-25694-1

Additional copies of this report are available for sale from The National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu/.

For more information about the Institute of Medicine, visit the IOM home page at www.iom.edu.

Copyright 2012 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America

The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The serpent adopted as a logotype by the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.

Suggested citation: IOM (Institute of Medicine). 2012. Public engagement on facilitating access to antiviral medications and information in an influenza pandemic: Workshop series summary. Washington, DC: The National Academies Press.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

“Knowing is not enough; we must apply.
Willing is not enough; we must do.”

                                                                     —Goethe

image

INSTITUTE OF MEDICINE
          OF THE NATIONAL ACADEMIES

Advising the Nation. Improving Health.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

THE NATIONAL ACADEMIES

Advisers to the Nation on Science, Engineering, and Medicine

The National Academy of Sciences is a private, nonprofit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Academy has a mandate that requires it to advise the federal government on scientific and technical matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.

The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engineers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineering programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. Dr. Charles M. Vest is president of the National Academy of Engineering.

The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Institute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. Dr. Harvey V. Fineberg is president of the Institute of Medicine.

The National Research Council was organized by the National Academy of Sciences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientific and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the National Research Council.

www.national-academies.org

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

PLANNING COMMITTEE ON PUBLIC ENGAGEMENT FOR DISTRIBUTION AND DISPENSING OF ANTIVIRAL MEDICATIONS: WORKSHOP SERIES1

ARTHUR KELLERMANN (Co-Chair), RAND Corporation, Santa Monica, CA

LISA KOONIN (Co-Chair), Influenza Pandemic Unit, Centers for Disease Control and Prevention, Atlanta, GA

ALEX ADAMS, National Association of Chain Drug Stores, Alexandria, VA

ROGER BERNIER, Centers for Disease Control and Prevention (former), Atlanta, GA

JAMES BLUMENSTOCK, Association of State and Territorial Health Officials, Arlington, VA

GREGORY BOGDAN, Rocky Mountain Poison and Drug Center, Denver, CO

SUSAN COOPER, Tennessee Department of Health (former), Nashville, TN

JACK HERRMANN, National Association of County and City Health Officials, Washington, DC

RUTH LYNFIELD, Minnesota Department of Health, Minneapolis, MN

SUZET McKINNEY, The Tauri Group, Alexandria, VA

JUDY MEEHAN, National Healthy Mothers Healthy Babies Coalition, Washington, DC

ELENA RIOS, National Hispanic Medical Association, Washington, DC

CAROL RUTENBERG, Telephone Triage Consulting, Inc., Hot Springs, AR

UMAIR SHAH, Harris County Department of Public Health and Environmental Services, Houston, TX

Project Staff

BRUCE M. ALTEVOGT, Preparedness Forum Director

KRISTIN VISWANATHAN, Research Associate

ANDREW M. POPE, Director, Board on Health Sciences Policy

ALEX REPACE, Senior Program Assistant

BARBARA FAIN, Public Engagement Consultant

___________________

1Institute of Medicine planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

FORUM ON MEDICAL AND PUBLIC HEALTH PREPAREDNESS FOR CATASTROPHIC EVENTS1

ROBERT KADLEC (Co-Chair), PRTM Management Consultants, Washington, DC

LYNNE KIDDER (Co-Chair), Bipartisan WMD Terrorism Research Center

ALEX ADAMS, National Association of Chain Drug Stores Foundation, Alexandria, VA

DAMON ARNOLD, Association of State and Territorial Health Officials, Arlington, VA (until November 2011)

GEORGES BENJAMIN, American Public Health Association, Washington, DC

D. W. CHEN, Office of Assistant Secretary of Defense for Health Affairs, Department of Defense, Washington, DC (until February 2012)

BROOKE COURTNEY, Food and Drug Administration, Silver Spring, MD

JEFFREY DUCHIN, Seattle & King County and University of Washington, Seattle

ALEXANDER GARZA, Department of Homeland Security, Washington, DC

JULIE GERBERDING, Merck Vaccines, West Point, PA

LEWIS GOLDFRANK, New York University Medical Center, NY

DAN HANFLING, Inova Health System, Falls Church, VA

JACK HERRMANN, National Association of County and City Health Officials, Washington, DC

JAMES JAMES, American Medical Association, Chicago, IL

PAUL JARRIS, Association of State and Territorial Health Officials, Arlington, VA

JERRY JOHNSTON, National Association of Emergency Medical Technicians, Mt. Pleasant, IA (until January 2012)

BRIAN KAMOIE, The White House, Washington, DC

LISA KAPLOWITZ, U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Washington, DC

___________________

1Institute of Medicine forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.

Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

ALI KHAN, Centers for Disease Control and Prevention, Atlanta, GA

MICHAEL KURILLA, National Institute of Allergy and Infectious Diseases, Bethesda, MD

JAYNE LUX, National Business Group on Health, Washington, DC

ANTHONY MACINTYRE, American College of Emergency Physicians, Washington, DC

NICOLE McKOIN, Target Corporation, Minneapolis, MN (from April 2012)

MARGARET McMAHON, Emergency Nurses Association, Williamstown, NJ

MATTHEW MINSON, Texas A&M University, College Station, TX

ERIN MULLEN, Pharmaceutical Research and Manufacturers of America, Washington, DC

CHERYL PETERSON, American Nurses Association, Silver Spring, MD

STEVEN PHILLIPS, National Library of Medicine, Bethesda, MD

LEWIS RADONOVICH, Veterans Health Administration, Washington, DC

JOSHUA RIFF, Target Corporation, Minneapolis, MN (until April 2012)

KENNETH SCHOR, Uniformed Services University of the Health Sciences, Bethesda, MD (since April 2012)

ROSLYNE SCHULMAN, American Hospital Association, Washington, DC

SARAH SEILER, Carolinas Medical Center, Charlotte, NC

RICHARD SERINO, Federal Emergency Management Agency, Washington, DC

MICHAEL SKIDMORE, U.S. Department of Defense, Washington, DC

SHARON STANLEY, American Red Cross, Washington, DC

ERIC TONER, University of Pittsburgh Medical Center, Pittsburgh, PA

REED TUCKSON, UnitedHealth Group, Minneapolis, MN

MARGARET VANAMRINGE, The Joint Commission, Washington, DC

GAMUNU WIEJETUNGE, National Highway Traffic Safety Administration, Washington, DC

IOM Staff

BRUCE ALTEVOGT, Project Director

ANDREW M. POPE, Director, Board on Health Sciences Policy

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

KRISTIN VISWANATHAN, Research Associate

ALEX REPACE, Senior Program Assistant

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

Reviewers

This workshop summary has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published summary as sound as possible and to ensure that the summary meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confidential to protect the integrity of the process. We wish to thank the following individuals for their review of this summary:

Terri Hyduke, Children’s Physician Network, Minneapolis, MN

Meredith Li-Vollmer, Seattle & King County, WA

Paul Petersen, State of Tennessee Department of Health, Nashville

Jo Ellen Warner, National Association of County and City Health Officials, Washington, DC

Although the reviewers listed above have provided many constructive comments and suggestions, they did not see the final draft of the summary before its release. The review of this summary was overseen by Herminia Palacio, Executive Director, Harris County Public Health and Environmental Services. Appointed by the Institute of Medicine, she was responsible for making certain that an independent examination of this summary was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the final content of this summary rests entirely with the rapporteurs and the institution.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×

This page intentionally left blank.

Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R1
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R2
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R3
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R4
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R5
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R6
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R8
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R9
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R10
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R11
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R12
Page xiii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R13
Suggested Citation:"Front Matter." Institute of Medicine. 2012. Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary. Washington, DC: The National Academies Press. doi: 10.17226/13404.
×
Page R14
Next: Introduction and Workshop Series Summary »
Public Engagement on Facilitating Access to Antiviral Medications and Information in an Influenza Pandemic: Workshop Series Summary Get This Book
×
Buy Paperback | $30.00 Buy Ebook | $23.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Influenza pandemics overwhelm health care systems with thousands or hundreds of thousands of sick patients, as well as those worried they may be sick. In order to ensure a successful response to the patient swell caused by a pandemic, robust planning is essential to prepare for challenges public health officials may face. This includes the need to quickly distribute and dispense antiviral medications that can reduce the severity and duration of disease to large numbers of people.

In response to a request from the Centers for Disease Control, the Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events held a series of workshops that explored the public's perception of how to facilitate access to antiviral medications and treatment during an influenza pandemic. To help inform potential strategies still in the development stages at the CDC, workshops were held in Fort Benton, Montana; Chattanooga, Tennessee; and Los Angeles, California during February and March 2012 to consider the usefulness of several alternative strategies of delivering antiviral medication to the public. Participants considered how the normal systems for prescribing and dispensing antiviral medications could be adjusted to ensure that the public has quick, safe, and equitable access to both potentially life-saving drugs and information about the pandemic and treatment options. This document summarizes the workshops.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!